Skip to main content
. 2022 Jul 25;14(15):3619. doi: 10.3390/cancers14153619
BCLC the Barcelona Clinic Liver Cancer
CT computed tomography
HCC hepatocellular carcinoma
ICI immune checkpoint inhibitors
mRECIST the modified Response Evaluation Criteria in Solid Tumors
NCI-CTCAE The National Cancer Institute–Common Terminology Criteria for Adverse Events
ORR overall response rate
OS overall survival
PFS progression-free survival
PVTT portal vein tumor thrombus
SBRT stereotactic body radiation therapy
SD standard deviation
TACE transcatheter arterial chemoembolization
TKI tyrosine kinase inhibitor